At the end of the latest market close, Proteostasis Therapeutics Inc. (PTI) was valued at $1.00. In that particular session, Stock kicked-off at the price of $1.00 while reaching the peak value of $1.245 and lowest value recorded on the day was $0.99. The stock current value is $1.23.
Recently in News on December 2, 2020, Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm – MVC, PTI, CGIX, STND. Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Proteostasis Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.3600 on 01/06/20, with the lowest value was $0.8700 for the same time period, recorded on 03/16/20.
Proteostasis Therapeutics Inc. (PTI) full year performance was -65.16%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Proteostasis Therapeutics Inc. shares are logging -73.94% during the 52-week period from high price, and 41.38% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.87 and $4.72.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3233821 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Proteostasis Therapeutics Inc. (PTI) recorded performance in the market was -46.05%, having the revenues showcasing -6.82% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 64.88M, as it employees total of 5 workers.
The Analysts eye on Proteostasis Therapeutics Inc. (PTI)
During the last month, 2 analysts gave the Proteostasis Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.2193, with a change in the price was noted -0.2700. In a similar fashion, Proteostasis Therapeutics Inc. posted a movement of -18.00% for the period of last 100 days, recording 701,900 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for PTI is recording 0.01 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of Proteostasis Therapeutics Inc. (PTI)
Raw Stochastic average of Proteostasis Therapeutics Inc. in the period of last 50 days is set at 70.85%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 94.34%. In the last 20 days, the company’s Stochastic %K was 38.88% and its Stochastic %D was recorded 23.28%.
Considering, the past performance of Proteostasis Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -46.05%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -18.00%, alongside a downfall of -65.16% for the period of the last 12 months. The shares increased approximately by 20.59% in the 7-day charts and went up by 9.82% in the period of the last 30 days. Common stock shares were lifted by -6.82% during last recorded quarter.